Millennium Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,056,349
| Closed | -$18.4M | – | 6844 |
|
|
2020
Q4 | $18.4M | Buy |
1,056,349
+191,456
| +22% | +$2.69M | 0.01% | 1136 |
|
|
2020
Q3 | $10.1K | Sell |
864,893
-87,446
| -9% | -$1.16M | 0.01% | 1237 |
|
|
2020
Q2 | $12.4M | Buy |
952,339
+250,980
| +36% | +$3.01M | 0.02% | 1063 |
|
|
2020
Q1 | $6.5M | Sell |
701,359
-241
| -0% | -$3.37K | 0.01% | 1143 |
|
|
2019
Q4 | $11.6M | Sell |
701,600
-613,787
| -47% | -$9.95M | 0.01% | 1260 |
|
|
2019
Q3 | $21.9M | Buy |
1,315,387
+197,364
| +18% | +$2.73M | 0.03% | 719 |
|
|
2019
Q2 | $15.4M | Buy |
1,118,023
+1,010,462
| +939% | +$15.5M | 0.02% | 950 |
|
|
2019
Q1 | $1.85M | Sell |
107,561
-10,353
| -9% | -$164K | ﹤0.01% | 2460 |
|
|
2018
Q4 | $1.51M | Buy |
117,914
+63,617
| +117% | +$965K | ﹤0.01% | 2371 |
|
|
2018
Q3 | $881K | Buy |
54,297
+37,563
| +224% | +$537K | ﹤0.01% | 2943 |
|
|
2018
Q2 | $216K | Sell |
16,734
-97,349
| -85% | -$1.32M | ﹤0.01% | 3533 |
|
|
2018
Q1 | $1.42M | Sell |
114,083
-68,522
| -38% | -$834K | ﹤0.01% | 2517 |
|
|
2017
Q4 | $2.55M | Buy |
182,605
+145,085
| +387% | +$2.13M | ﹤0.01% | 2135 |
|
|
2017
Q3 | $630K | Sell |
37,520
-1,424
| -4% | -$23.2K | ﹤0.01% | 2741 |
|
|
2017
Q2 | $655K | Sell |
38,944
-14,364
| -27% | -$215K | ﹤0.01% | 2669 |
|
|
2017
Q1 | $826K | Buy |
+53,308
| New | +$761K | ﹤0.01% | 2517 |
|
Millennium Management's OXFD Position: Q1 2021 in Review
Millennium Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 1,056,349 shares — an estimated $18.4M sold.
Millennium Management first reported a position in OXFD in Q1 2017 and held it in 16 quarters. The position peaked at $21.9M in Q3 2019. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Millennium Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Millennium Management sold 1,056,349 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $18.4M.
- Millennium Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 16 quarters.
- Millennium Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $21.9M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Millennium Management's 13F filing for Q1 2021, filed 17 May 2021.